XML 39 R29.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2025
Stockholders’ Equity [Line Items]  
Schedule of Preferred Stock Outstanding

All series of the Company’s convertible preferred stock include alternate conversion provisions. The Company’s convertible preferred stock also contains floor pricing provisions; the Company has the discretion to issue shares below the floor price.

 

Aditxt Preferred Share Class  Quantity
Issued and
Outstanding
as of
June 30,
2025		   Standard
Conversion
Common
Stock
Equivalent		   Liquidation
Amount		 
Series A Preferred Stock   
-
    
-
   $
-
 
Series A-1 Convertible Preferred Stock   21,803    2,456    27,253,448 
Series B Preferred Stock   
-
    
-
    
-
 
Series B-1 Convertible Preferred Stock   2,689    332    3,361,250 
Series B-2 Convertible Preferred Stock   2,625    279    3,281,250 
Series C Preferred Stock   
-
    
-
    
-
 
Series C-1 Convertible Preferred Stock   2,263    88    2,828,305 
Series D-1 Preferred Stock   
-
    
-
    
-
 
Total Aditxt Preferred Shares Outstanding   29,380    3,155   $36,724,253 
Schedule of Analysis of the Stock Option Grant Activity under the Plan

The following is an analysis of the stock option grant activity under the Plan: 

 

Vested and Nonvested Stock Options  Number   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Life		 
Outstanding December 31, 2024   60   $44,395,124.59    6.10 
Granted   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Expired or forfeited   (1)   150,200,000.00    
-
 
Outstanding June 30, 2025   59   $40,808,518.64    5.81 

The following is an analysis of the stock option grant activity under the Pearsanta Plans:

 

Vested and Nonvested Stock Options  Number   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Life		 
Outstanding December 31, 2024   181,227   $1.19    8.84 
Granted   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Expired or forfeited   
-
    
-
    
-
 
Rounding in connection with Reverse Split   
-
    
-
    
-
 
Outstanding June 30, 2025   181,227   $1.19    8.34 

A summary of warrant issuances are as follows:

 

Vested and Nonvested Warrants  Number   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Life		 
Outstanding December 31, 2024   2,680   $659,707.35    4.51 
Granted   600,000    2.00    1.98 
Exercised   
-
    
-
    
-
 
Expired or forfeited   
-
    
-
    
-
 
Outstanding June 30, 2025   602,680   $2,935.58    1.99 
Schedule of Nonvested Stock Options
Nonvested Stock Options  Number   Weighted-
Average
Exercise
Price		 
Nonvested on December 31, 2024   
-
   $
-
 
Granted   
-
    
-
 
Vested   
-
    
-
 
Forfeited   
-
    
-
 
Nonvested on June 30, 2025   
             -
   $
                 -
 
Nonvested Stock Options  Number   Weighted-
Average
Exercise
Price		 
Nonvested on December 31, 2024   
-
   $
-
 
Granted   -    
-
 
Vested   
-
    
-
 
Forfeited   
          -
    
         -
 
Nonvested on June 30, 2025   
-
   $
-
 
Nonvested Warrants  Number   Weighted-
Average
Exercise
Price		 
Nonvested on December 31, 2024   
-
   $
-
 
Granted   600,000    2.00 
Vested   (600,000)   2.00 
Forfeited   
-
    
-
 
Nonvested on June 30, 2025   
-
   $
-
 
Schedule of Fair Value of Option Granted

For the period ended June 30, 2025, the fair value of each warrant granted with the notes receivable was estimated using the assumption and/or factors in the Black-Scholes Model as follows:

 

Exercise price  $0.0154 
Expected dividend yield   0%
Risk free interest rate   7.79-3.88%
Expected life in years   0.50-0.73 
Expected volatility   175-180%
Warrant [Member]  
Stockholders’ Equity [Line Items]  
Schedule of Fair Value of Option Granted

For the year ended December 31, 2024, the fair value of each warrant granted was estimated using the assumption and/or factors in the Black-Scholes Model as follows:

 

Exercise price  $2.00 
Expected dividend yield   0%
Risk free interest rate   3.75%
Expected life in years   1.0 
Expected volatility   190%